Bioequivalence of Hanacef Capsule to Duricef Capsule (Cefadroxil 500 mg) |
Cho, Hea-Young
(College of Pharmacy and Research Institute of Drug Development, Chonnam National University)
Lee, Suk (College of Pharmacy and Research Institute of Drug Development, Chonnam National University) Moon, Jai-Dong (Medical School, Chonnam National University) Lee, Yong-Bok (College of Pharmacy and Research Institute of Drug Development, Chonnam National University) |
1 | R.H. Barbhaiya, A pharmacokinetic comparision of cefadroxil and cephalexin after administration of 250, 500 and 1000 mg solution doses, Biopharm. Drug Disp., 17, 319-330 (1996) DOI ScienceOn |
2 | 식품의약품안전청 고시 제 2001-57호, 생물학적 동등성 시험기준 (2001. 9. 5) |
3 | K. Lindgren, Determination of cefadroxil in serum by highperformance liquid chromatography with cephradine as internal standard, J. Chromatogr., 413, 347-350 (1987) DOI ScienceOn |
4 | Statistical Solution Ltd., Equiv Test_ 1.0, U.K. (1998) |
5 | Food and Drug Administration (FDA): Guidance for Industry; Waiver of in vivo bioavailability and bioequiva- lence study for immediate-release solid oral dosage forms based on a biopharmaceutics classification system, Center for Drug Evaluation and Research (CDER), August (2000) |